About ALDR

Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder’s lead clinical candidate, ALD403, inhibits a well validated molecule shown to trigger migraine attacks, calcitonin gene-related peptide (CGRP), and is currently undergoing Phase 2b clinical testing for the treatment of chronic migraines. Alder has initiated a pivotal clinical trial for the treatment of frequent episodic migraine and plans to initiate additional advanced clinical trials for ALD403 in frequent episodic and chronic migraine in 2016. Alder’s second program, ALD1613, which targets adrenocorticotropic hormone (ACTH) is undergoing Investigational New Drug (IND)-enabling preclinical studies with the initiation of clinical trials in Congenital Adrenal Hyperplasia or Cushing’s disease planned for 2016. Finally, clazakizumab, previously known as ALD518, is designed to block the pro-inflammatory cytokine IL-6 and has completed a Phase 2b clinical trial. Alder is seeking a partner or other strategic alternatives for clazakizumab.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALDR is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 212.2 M 2.1215E+08 234 234 0.05% 0.0005193 242 K 241644
UBIO Proshares UltraPro Nasdaq Biotechnology 28.4 M 2.839E+07 227 227 0.03% 0.000332902 31 K 30846
URTY ProShares UltraPro Russell2000 90.7 M 9.07335E+07 1,993 1993 0.01% 7.42163E-05 22 K 22080
UWM ProShares Ultra Russell2000 158.8 M 1.5876E+08 1,992 1992 0.01% 0.000124957 43 K 43166
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.0 B 1.9747E+09 1,475 1475 0.01% 0.00011 224 K 223899
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.39704E+09 2,261 2261 0.0% 2.9E-05 41 K 40824
VB Vanguard Small-Cap ETF 23.6 B 2.36E+10 1,376 1376 0.02% 0.00023 5.4 M 5376920
VBK Vanguard Small-Cap Growth ETF 8.4 B 8.4E+09 619 619 0.05% 0.00048 4.0 M 4024910
VHT Vanguard Health Care ETF 8.7 B 8.7E+09 393 393 0.02% 0.00017 1.5 M 1496560
VTHR Vanguard Russell 3000 ETF 424.7 M 4.247E+08 2,959 2959 0.0% 2E-05 9 K 9486
VTI Vanguard Total Stock Market ETF 108.6 B 1.086E+11 3,570 3570 0.0% 2E-05 1.8 M 1756950
VTWG Vanguard Russell 2000 Growth ETF 282.8 M 2.828E+08 1,257 1257 0.05% 0.00051 144 K 144168
VTWO Vanguard Russell 2000 ETF 1.4 B 1.4E+09 2,010 2010 0.03% 0.00033 463 K 462964
VTWV Vanguard Russell 2000 Value ETF 238.7 M 2.387E+08 1,374 1374 0.01% 0.00013 30 K 30112
VXF Vanguard Extended Market ETF 6.5 B 6.5E+09 3,237 3237 0.02% 0.00016 1.1 M 1064040
LABU Direxion Daily S&P Biotech Bull 3X Shares 574.4 M 5.74419E+08 130 130 0.09% 0.000856506 1.7 M 1711940
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.33983E+09 221 221 0.13% 0.0013 9.3 M 9347780
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.0 B 2.09757E+10 3,548 3548 0.0% 0 511 K 511258
IWM iShares Russell 2000 ETF 40.8 B 4.08254E+10 1,983 1983 0.03% 0.0003 13.6 M 1.35591E+07
IWN iShares Russell 2000 Value ETF 8.7 B 8.67212E+09 1,350 1350 0.01% 0.0001 1.1 M 1127890
IWO iShares Russell 2000 Growth ETF 8.9 B 8.86158E+09 1,229 1229 0.05% 0.0005 4.5 M 4487110
IWV iShares Russell 3000 ETF 9.4 B 9.36465E+09 2,927 2927 0.0% 0 233 K 233162
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.3 B 4.27996E+09 121 121 0.49% 0.00493894 21.7 M 2.167222E+07
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 369 369 0.02% 0.000165146 261 K 261206
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.01% 9.6571E-05 205 K 205277